Pre-Exposure Prophylaxis for Coronavirus
The University of Minnesota, in collaboration with Vanderbilt University and Oregon Health and Science University, is conducting a research study to determine if taking a medication called hydroxychloroquine (Plaquenil) can help in preventing COVID-19 disease (commonly referred to as coronavirus).
Why are doing this study?
The University of Minnesota is conducting a research study to determine if taking a medication hydroxychloroquine (Plaquenil) can help prevent COVID-19. There is an optional sub study testing Covid-19 antibodies at enrollment and at the end of the study.
We want to find out:
- If hydroxychloroquine can prevent COVID-19
- What proportion of healthcare workers have positive antibodies at the time they enroll
- What proportion of healthcare workers develop positive antibodies by the end of the study
Who are we looking for?
We are looking for participants who are healthcare workers in settings that are high risk for exposure to COVID-19:
- Persons primarily working in emergency departments (physicians, nurses, physician assistants, ancillary staff, triage personnel)
- Persons primarily working in intensive care units (physicians, nurses, ancillary staff, respiratory therapists)
- Persons primarily working in urgent care centers or clinics (physicians, nurses, physician assistants)
- Persons primarily working in congregate care facilities (long-term care facilities, nursing homes, group homes)
- Persons performing aerosol generating procedures (ex. anesthesiologists, nurse anesthetists (CRNAs))
- First responders (ex: EMTs, paramedics)
Want to participate? Learn more about the trial.